Publication | Closed Access

Treatment of Renal Transplant Recipients With Low Bone Mineral Density: A Randomized Prospective Trial of Alendronate, Alfacalcidol, and Alendronate Combined With Alfacalcidol

Bone DiseaseUrologyBone HealthKidney TransplantKidney TransplantationRenal Transplant RecipientsRandomized Prospective TrialAlendronate CombinedNephrologyMedicineOsteoporosisBone Metabolism